• Return to Headlines

Heron Therapeuti Down 28.8% Since SmarTrend Downtrend Call (HRTX)

By James Quinn

SmarTrend identified a Downtrend for Heron Therapeuti (NASDAQ:HRTX) on March 15th, 2019 at $23.97. In approximately 5 months, Heron Therapeuti has returned 28.81% as of today's recent price of $17.06.

Heron Therapeuti share prices have moved between a 52-week high of $41.10 and a 52-week low of $15.68 and are now trading 9% above that low price at $17.06 per share. Over the past week, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has remained constant.

Heron Therapeutics, Inc. operates as a biotechnology company. The Company offers proprietary biochronomer drug delivery technology which is designed to improve the therapeutic profile of injectable pharmaceuticals, as well as focuses on identifying current therapies with the potential to be reformulated.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Heron Therapeuti.

Log in and add Heron Therapeuti (HRTX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights heron therapeuti

Ticker(s): HRTX